Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. (2021)
Attributed to:
An integrated biophysics approach towards realisation of a new class of membrane-active anticancer therapies
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-021-01720-w
PubMed Identifier: 33742124
Publication URI: http://europepmc.org/abstract/MED/33742124
Type: Journal Article/Review
Volume: 40
Parent Publication: Oncogene
Issue: 16
ISSN: 0950-9232